Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphoma
We developed an innovative prognostic MitoRGs signature to predict outcomes and enhance the prognostic utility of the IPI score in DLBCL, offering a novel perspective for the treatment of DLBCL.
Authors
- Yu Gao (ORCID: https://orcid.org/0000-0001-5090-8250)
- Fujue Wang (ORCID: https://orcid.org/0000-0002-5360-1235)
- Yao Zeng (ORCID: https://orcid.org/0000-0002-2070-3577)
- Pian Li
- Yongsheng Wang (ORCID: https://orcid.org/0000-0003-3673-8376)
- Yung‐Ming Chen (ORCID: https://orcid.org/0000-0002-9241-1258)
- Yongqian Jia
- Yonghui Yin (ORCID: https://orcid.org/0009-0008-9690-5299)
- Yue Chen (ORCID: https://orcid.org/0000-0001-7991-1250)
Institutions
- University of Electronic Science and Technology of China (CN)
- Guangxi Medical University (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Tumor Hospital of Guangxi Medical University (CN)
- State Key Laboratory of Biotherapy
- University of South China (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3389/fonc.2025.1542829
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94